Series: Increasing the Scope of your Analytical Toolbox with UltraPerformance Convergence Chromatography (UPC2) - Episode 1
Wednesday, November 14, 2012
9:00 AM EST; 15:00 (GMT + 1)
Series: Increasing the Scope of your Analytical Toolbox with UltraPerformance Convergence Chromatography (UPC2)
Do you know what your next sample will be? Could it be hydrophobic, hydrophilic, volatile, non-volatile or chiral? Are you being challenged to reduce toxic solvent waste and go green? Which technique will you choose from your analytical toolbox to get the best possible separation?
In this webcast series, we’ll discuss how analytical laboratories can benefit from UltraPerformance Convergence Chromatography™ (UPC²™) a new category of separation science that provides an exponential increase in performance and selectivity to the chromatographic laboratory. Through a variety of topics and scientific examples, this series will help you to gain a better understanding of UPC² technology, how to realize its benefits and how to easily adopt it into your laboratory.
Attendees of today’s webcast will learn about the key features of the ACQUITY UPC² System and how to implement the right strategy for achiral method development, achieving successful separations across a wide range of compounds in all industries
Sponsored by: Waters Corporation
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Multivariate Design of Experiments for Gas Chromatographic Analysis
November 1st 2024Recent advances in green chemistry have made multivariate experimental design popular in sample preparation development. This approach helps reduce the number of measurements and data for evaluation and can be useful for method development in gas chromatography.